Company & Sponsor Intelligence
Xijing Hospital
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials13
Recruiting4
Completed3
Countries1
Therapeutic footprint
adhdalzheimersanxietyepilepsyother_neurologyout_of_scopesleep_disordersstroke
Indexed studies
NCT04726007Management of TA in VaS-Patients and HT
stroke · ChinaUNKNOWN
stroke · ChinaUNKNOWN
NCT07448233Application of an AI-Based Health Management System in Long-Term Epilepsy Management in Rural Areas
epilepsy · ChinaNA
epilepsy · ChinaNA
NCT02982655Controlling Hypertension After Severe Cerebrovascular Event
stroke · ChinaNA
stroke · ChinaNA
NCT07114224Aβ PET and Tau PET Imaging in the Diagnosis and Progression Assessment of Alzheimer's Disease
alzheimers · NA
alzheimers · NA
NCT03447223Gut Microbiome and Serum Metabolome Alterations in ADHD Patients
adhd · ChinaCOMPLETED
adhd · ChinaCOMPLETED
NCT07378163Study on the Preferences for PCI Implantation Devices Among Doctors and Patients
out_of_scope · ChinaRECRUITING
out_of_scope · ChinaRECRUITING
NCT03018574Candidate Gene Screening for Attention Deficit/Hyperactive Disorder (ADHD)
adhd · ChinaCOMPLETED
adhd · ChinaCOMPLETED
NCT07730762A Study of Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) for Insomnia During Pregnancy
sleep_disorders · ChinaNA
sleep_disorders · ChinaNA
NCT05032053Antithrombotic Drug Use in Patients With Ischemic Stroke and Microbleeds
stroke · ChinaRECRUITING
stroke · ChinaRECRUITING
NCT06134323Transcutaneous Vagus Nerve Stimulation for Generalized Anxiety Disorder
anxiety · ChinaNA
anxiety · ChinaNA
NCT02278016Biological Markers for the Diagnosis of Central Nervous System Infective Diseases
other_neurology · ChinaUNKNOWN
other_neurology · ChinaUNKNOWN
NCT01924325Apixaban Versus Dual-antiplatelet Therapy (Clopidogrel and Aspirin) in Acute Non-disabling Cerebrovascular Events
stroke · ChinaPHASE2, PHASE3
stroke · ChinaPHASE2, PHASE3
Intelligence layer updated: 2026-10-11 23:31:09.606883+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →